Ionis Pharmaceuticals reported $150.23M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Agios Pharmaceuticals USD -125797000 20.45M Jun/2025
Alnylam Pharmaceuticals USD 18.83M 13.65M Jun/2025
Arrowhead Research USD -159327000 556.67M Jun/2025
Astellas Pharma JPY 140.34B 29.56B Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Celltrion KRW 221.03B 57.43B Mar/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Divis Laboratories Ltd 7.29B 2.43B Jun/2025
Exelixis USD 220.92M 26.71M Jun/2025
Halozyme Therapeutics USD 225.5M 63.51M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
Kangmei Pharma -3262057.35 15.91M Sep/2024
Knight Therapeutics CAD 16.72M 1.05M Sep/2024
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1100000 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Moderna USD -760000000 164M Jun/2025
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Neurocrine Biosciences USD 152.9M 121.6M Jun/2025
Novartis USD 6.17B 339M Jun/2025
OPKO Health USD -69166000 56.37M Jun/2025
Organigram Holdings CAD 2.68M 18.86M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Pharma Mar EUR 26.15M 27.2M Jun/2025
PTC Therapeutics USD 971.14M 970.07M Mar/2025
Qiagen NV USD 208.98M 38.23M Jun/2025
Regeneron Pharmaceuticals USD 1.66B 926.5M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Sartorius EUR 264.3M 1.3M Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Tilray USD -101000 2.32M Nov/2024
Ultragenyx Pharmaceutical USD -91344000 35.09M Jun/2025
Vertex Pharmaceuticals USD 1.34B 556.6M Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 1.19B 829.65M Mar/2025